Inhaled colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: A real-life experience in tertiary care hospitals in Saudi Arabia

BACKGROUND: Nosocomial pneumonia (NP) due to multidrug-resistant (MDR) Gram-negative pathogens, has continued to rise over the last several decades. Parenteral administration of colistin results in poor alveolar penetration and subtherapeutic concentration; therefore, direct drug deposition at site...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Saudi Pharm J
Main Authors: Almangour, Thamer A., Alenazi, Basel, Ghonem, Leen, Alhifany, Abdullah A., Aldakheel, Bassam A., Alruwaili, Alya
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7414068/
https://ncbi.nlm.nih.gov/pubmed/32792845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsps.2020.06.023
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados